Reshaping the gut microbiome and bile acid composition by Gyejibongnyeong-hwan ameliorates western diet-induced dyslipidemia
Gyejibongnyeong-hwan (GBH), a traditional Chinese medicine, is used in clinical practice to treat blood stasis in metabolic diseases. Herein, we examined the effects of GBH on dyslipidemia and investigated the underlying mechanisms by focusing on modulation of the gut microbiota-bile acid axis by GB...
Main Authors: | So Min Lee, You Mee Ahn, Seong-Hwan Park, Sarah Shin, Jeeyoun Jung |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-07-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332223006169 |
Similar Items
-
Gyejibongnyeong-Hwan (Gui Zhi Fu Ling Wan) Ameliorates Human Uterine Myomas via Apoptosis
by: So Min Lee, et al.
Published: (2019-09-01) -
Effectiveness of Gyejibongnyeong-Hwan for shoulder pain: study protocol for a randomised, wait-list controlled pilot trial
by: Soobin Jang, et al.
Published: (2020-02-01) -
The genotoxicity of an aqueous extract of Gyejibokryeong-hwan
by: Mee-Young Lee, et al.
Published: (2018-01-01) -
Effects of Sedang-hwan on Experimental Diabetic Rats induced by Streptozotocin
by: Chul-Ho Bae, et al.
Published: (2006-02-01) -
Physiological Role of Bile Acids Modified by the Gut Microbiome
by: Yoshimitsu Kiriyama, et al.
Published: (2021-12-01)